Skip to content
Review Open access

Effect of Yoga on Ventricular Premature Complex Burden and Quality of Life

Sep 2026 · JACC: Advances · Vol 5 · 0 citations · 32 references
Medicine

TL;DR

Yoga as an adjunct therapeutic modality reduced VPC burden and improved QoL and psychological burden in patients with frequent VPCs and it may be useful to integrate a cost-effective, nonpharmacological intervention like yoga in the management of patients with frequent VPCs.

Abstract

Background Ventricular premature complexes (VPCs) are common cardiac arrhythmias with prognostic significance depending on clinical context and arrhythmia burden. Yoga modulates autonomic tone and may improve cardiac dysautonomia, including arrhythmias, while enhancing quality of life (QoL). Objectives The objective of the study was to evaluate the efficacy of adjunctive yoga-based intervention on VPC burden, QoL, and left ventricular ejection fraction in patients with frequent VPCs. Methods In this single-center, prospective, randomized controlled trial, 134 patients with frequent VPCs (burden ≥5% on 24-hour Holter monitoring) were randomized (1:1) to a structured yoga intervention (n = 67) or standard care (n = 67) and followed for 24 weeks. The primary outcome was change in VPC burden. Secondary outcomes included QoL (36-Item Short Form Survey), left ventricular ejection fraction, major adverse cardiac and cerebrovascular events, psychological outcomes (Depression, Anxiety and Stress Scale-21 Items), and heart rate variability. Results The baseline VPC burden was higher in the control group than in the yoga group (21.06 [10.48-34.67] vs 13.02 [8.87-21.60]). At 6 weeks, both groups demonstrated a reduction in VPC burden (control: 19.19 [7.50-30.70]; yoga: 11.62 [5.83-21.59]). A statistically significant between-group difference was observed at 12 weeks (P = 0.02). At 24 weeks, the yoga group showed significantly better 36-Item Short Form Survey scores across all domains and Depression, Anxiety and Stress Scale-21 Items scores. Conclusions Yoga as an adjunct therapeutic modality reduced VPC burden and improved QoL and psychological burden in patients with frequent VPCs. It may be useful to integrate a cost-effective, nonpharmacological intervention like yoga in the management of patients with frequent VPCs. (Effect of Yoga-based intervention on VPC burden, quality of life and LV functions in patients with Ventricular premature complexes [VPC]: A Randomized controlled Trial; CTRI/2021/06/034450).

Read PDF

Similar papers

Open access Aug 2026

“Synergistic Effects of Nutritional, Cognitive, and Cardiac Rehabilitation Parameters on Prognosis in Patients with Systolic Heart Failure”

The results suggested that the addition of cardiac rehabilitation parameters to the nutritional and cognitive status of patients with HF is synergically useful for risk stratification in predicting prognosis.

Rintaro Furuoka, Takahiro Doi, Satoshi Kimura et al. · 0 citations
Open access 2026

Chronic Fatigue in Adolescents: The Role of Congenital Heart Disease vs. Psychosocial Factors

: Background: Fatigue is a prevalent clinical complaint in adolescence, but its determinants—particularly in congenital heart disease (CHD)—remain poorly understood. Objective: This study aimed to compare the severity and multidimensional profile of fatigue symptoms between adolescents with corrected CHD and school-bas...

E. Likhomanova, Olga Shevaldova, A. Kovaleva et al. · 0 citations
Open access Oct 2026

Physical activity and quality of life in patients with hypertrophic cardiomyopathy in Japan: a quantitative study

ABSTRACT Aim To describe the burden of hypertrophic cardiomyopathy (HCM) using patient-reported outcome tools and a study-specific questionnaire. Patients and methods This two-phase, cross-sectional, non-interventional, observational study (qualitative [previous] and quantitative [current]) included adults with HCM and...

H. Kitaoka, Toru Kubo, Makio Torigoe et al. · 0 citations
Open access Oct 2026

Dapagliflozin’s impact on health-related quality of life and mortality in patients of chronic heart failure with reduced ejection fraction: a randomized controlled trial

Objective: To explore the impact of dapagliflozin on health-related quality of life, functional status and mortality in chronic heart failure with reduced ejection fraction patients. Method: The randomized controlled trial was conducted from April 2023 to May 2024 at the Department of Pharmacology and Therapeutics, Arm...

S. Rafique, Kulsoom Farhat, Mudassar Noor et al. · 0 citations
Open access Aug 2026

FREQUENCY OF CLINICAL DEPRESSION AND EFFECT OF ANTIDEPRESSANT TREATMENT ON OUTCOMES IN HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) AT PIMS

Background: Heart Failure with Reduced Ejection Fraction (HFrEF) is frequently associated with clinical depression, which adversely affects treatment adherence, self-care, healthcare utilization, and clinical outcomes. Evidence regarding the effect of antidepressant therapy on both psychological and cardiovascular outc...

Sulaiman Tahir, Akhtar Ali, Hayat Ullah et al. · 0 citations
Review Open access Sep 2026

Effects of Sauna and Waon Therapy on Cardiovascular Function and Clinical Outcomes in Patients with Chronic Heart Failure or Coronary Artery Disease: Systematic Review

Cardiovascular diseases, particularly chronic heart failure (CHF) and coronary artery disease (CAD), impose a significant global burden with persistent symptoms despite standard therapies. Sauna therapy, including Waon and Finnish sauna, induces physiological responses such as vasodilation and autonomic modulation, s...

S. Rammohan, D. Sathyanath, Shrikanth Muralidharan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.